Global Fund Observer

Global Fund Observer is the leading independent voice providing insight, analysis and opinion about the Global Fund. For authoritative and credible explanations about the policies, practices and procedures at the Secretariat, to insider information about Global Fund Board meetings, to real stories capturing the impact and role of the Global Fund at the country level, subscribe to our free twice-monthly newsletter.

To avoid the risk of your email system treating incoming issues of Global Fund Observer as spam, you should add to your list of approved email senders. If you are not sure how to do this, speak to your system administrator or technical support person.

Latest GFO Live articles

GFO Current Issue


Needle exchange and opioid substitution therapy programs are a small but resourceful response to a growing threat of injected drug use (IDU) in sub-Saharan Africa, which is beginning to drive the HIV epidemic and threatens to undermine the investment in reducing the burden of disease. 


Domestic expenditures for health are particularly vital, and developing countries are already making greater investments in their own health systems. Through the Global Fund’s 2015-2017 concept note process, implementing countries have committed $3.9 billion to date in domestic financing. Mobilizing these funds will help ensure program sustainability as countries transition from international support.


The Office of the Inspector General has launched a new platform for individuals to report allegations of human rights violations occurring in programs or activities supported by the  Global Fund. 


The International HIV/AIDS Alliance in Ukraine will lead a new regional technical assistance project across Eastern Europe and Central Asia.The project, to ensure that knowledge, skills and experience -- with particular emphasis on community systems, rights and gender -- are transferred and ingrained in local groups, will be supported by the Global Fund's Community, Rights and Gender (CRG) Special Initiative and will run through 2017.